1. Arteaga C, Kitten L, Coronado E et al. (1989) Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in nude mice. J Clin Invest 84: 1418–1423
2. Carter P, Presta L, Gorman C et al. (1992) Humanization of an anti-p185-HER2 antibody for human cancer treatment. Proc Natl Acad Sci USA 89: 4285–4289
3. Drebin J, Link V, Greene M (1988) Monoclonal antibodies specific for the neu oncogene product directly mediate anti-tumor effects in vivo. Oncogene 2: 387–394
4. Filmus J, Trent J, Pollak M, Buick R (1987) EGF receptor gene-amplified MDA-468 breast cancer cell line and its non-amplified variants’: Mol Cell Biol 7: 251–257
5. Furman-Haran E, Maretzek A, Goldberg I, Horowitz A, Degani H (1994) Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth. Cancer Res 54: 5511–5514